Pharmacokinetics and metabolism of pirarubicin in advanced cancer patients
- 1 August 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (8) , 1289-1294
- https://doi.org/10.1016/0277-5379(88)90217-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- (2?-R)-4?-o-Tetrahydropyranyladriamycin, a new anthracycline derivative; its effectiveness in lymphoid malignanciesCancer Chemotherapy and Pharmacology, 1987
- Pharmacokinetics of doxorubicin in sarcoma patientsEuropean Journal of Clinical Pharmacology, 1987
- Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patientsLeukemia Research, 1987
- Relationship between the intracellular level and growth inhibition of a new anthracycline 4′O-tetrahydropyranyl-adriamycin in friend leukemia cell variantsLeukemia Research, 1985
- Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.The Journal of Antibiotics, 1983
- 4'-O-TETRAHYDROPYRANYLADRIAMYCIN AS A POTENTIAL NEW ANTI-TUMOR AGENT1982
- Extraction of Anthracyclines from Biological Fluids for HPLC EvaluationJournal of Liquid Chromatography, 1980
- Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy.The Journal of Antibiotics, 1979
- Tetrahydropyranyl derivatives of daunomycin and adriamycin.The Journal of Antibiotics, 1979
- Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological FluidsJournal of Liquid Chromatography, 1978